Rankings
▼
Calendar
BCRX Q1 2016 Earnings — BioCryst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
Gross Profit
$5M
98.4% margin
Operating Income
-$19M
-395.2% margin
Net Income
-$23M
-473.7% margin
EPS (Diluted)
$-0.31
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$22M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$103M
Total Liabilities
$75M
Stockholders' Equity
$28M
Cash & Equivalents
$13M
← FY 2016
All Quarters
Q2 2016 →
